ISTAART Voices

In this episode of ISTAART Voices, Dr. Sietske Sikkes and Dr. Mark Dubbelman reveal the complex challenges of pooling data from multiple Alzheimer's disease clinical trials. Their research highlights significant barriers in accessing and analyzing historical trial data, demonstrating the critical need for more open and streamlined scientific collaboration. This discussion underscores the importance of making clinical trial data more accessible to advance personalized medicine and understanding of Alzheimer's disease treatment responsiveness.

Special thanks to ISTAART Ambassador Lucy Core for her contributions to the production of this episode of ISTAART Voices.

Links
Show page: alz.org/ISTAARTpodcast
ISTAART: alz.org/ISTAART
Featured paper: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.12485
Dr. Mark A. Dubbelman: https://connects.catalyst.harvard.edu/Profiles/display/Person/213733
Dr. Sietske A. M. Sikkes: https://research.vu.nl/en/persons/sietske-sikkes
Professional Interest Areas (PIAs): alz.org/ISTAARTPIAS
Podcast CMEs: alz.org/ISTAARTpodcastCME
Alzheimer's Association International Conference® 2025 (AAIC®): alz.org/AAIC
Alzheimer's Association Scientific Meetings: alz.org/scientificmeetings
Alzheimer's Association Journal Family: alz.org/journals
Social: #ISTAART @ISTAART

The views and opinions expressed in this podcast are solely those of the guests and do not necessarily reflect those of the Alzheimer's Association. The Alzheimer's Association does not endorse any external product or service. This podcast is for informational purposes and is not intended to provide medical advice, please consult your physician.
Hosted on Acast. See acast.com/privacy for more information.

In this episode, Dr. Sylvie Belleville talks through the latest results from a trial involving older adults experiencing mild cognitive impairment. This work emphasizes how targeted cognitive training and memory interventions could potentially slow the progression of mild cognitive impairment and may help sustain long-term cognitive function. The trial results offer compelling perspectives on non-pharmacological interventions for delaying the onset of dementia in individuals experiencing early cognitive changes.

Special thanks to ISTAART Ambassador James Brady for his contributions to the production of this episode of ISTAART Voices.

Links
Show page: alz.org/ISTAARTpodcast
ISTAART: alz.org/ISTAART
Featured paper: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/dad2.12626/utm_source=podcast&utm_medium=newsletter&utm_campaign=IVS1_SB&utm_id=ISTAARTVoicesTAARTVoices
Dr. Sylvie Belleville: https://recherche.umontreal.ca/english/our-researchers/professors-directory/researcher/is/in14272/
Podcast CMEs: www.alz.org/ISTAARTpodcastCME
Alzheimer's Association International Conference® 2025 (AAIC®): alz.org/AAIC
Alzheimer's Association Scientific Meetings: alz.org/scientificmeetings
Alzheimer's Association Journal Family: alz.org/journals
Social: #ISTAART @ISTAART

The views and opinions expressed in this podcast are solely those of the guests and do not necessarily reflect those of the Alzheimer's Association. The Alzheimer's Association does not endorse any external product or service. This podcast is for informational purposes and is not intended to provide medical advice, please consult your physician.

Hosted on Acast. See acast.com/privacy for more information.

Stressful life events like divorce and widowhood can have profound effects on brain health. In this episode of ISTAART Voices, Dr. Avinash Chandra shares his research exploring how marital dissolution may contribute to increased amyloid pathology and memory decline. His study offers compelling insights into the intricate relationship between life stress, brain biology, and cognitive aging, paving new avenues for understanding dementia risk factors.

Links
Show page: alz.org/ISTAARTpodcast
ISTAART: alz.org/ISTAART
Featured paper: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/dad2.70032/utm_source=podcast&utm_medium=newsletter&utm_campaign=IVS1_AC&utm_id=ISTAARTVoices
Dr. Avinash Chandra: https://www.qmul.ac.uk/wiph/people/profiles/chandra-avinash.html
Podcast CMEs: www.alz.org/ISTAARTpodcastCME
Alzheimer's Association International Conference® 2025 (AAIC®): alz.org/AAIC
Tau Tau Global Conference 2025: alz.org/tau
Alzheimer's Association Scientific Meetings: alz.org/scientificmeetings
Alzheimer's Association Journal Family: alz.org/journals
Social: #ISTAART @ISTAART

The views and opinions expressed in this podcast are solely those of the guests and do not necessarily reflect those of the Alzheimer's Association. The Alzheimer's Association does not endorse any external product or service. This podcast is for informational purposes and is not intended to provide medical advice, please consult your physician.
Hosted on Acast. See acast.com/privacy for more information.

New anti-amyloid therapies are transforming the treatment landscape for Alzheimer's disease. In this episode of ISTAART Voices, Dr. Gregory Jicha and Dr. Peter Nelson compare emerging Alzheimer's treatments to biologics used in cancer and other diseases. Their insightful analysis highlights the significance of new disease-modifying therapies, further illustrating why choices and access to treatment are crucial for individuals living with Alzheimer's disease.

Special thanks to ISTAART Ambassador Shloka Dhareshwar for her contributions to the production of this episode of ISTAART Voices.

Links
Show page: alz.org/ISTAARTpodcast
ISTAART: alz.org/ISTAART
Featured paper: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.12500?utm_source=podcast&utm_medium=newsletter&utm_campaign=IVS1_GJPN&utm_id=ISTAARTVoices
Gregory A. Jicha: https://medicine.uky.edu/users/gajich2
Peter T. Nelson: https://medicine.uky.edu/users/pnels2
Clinicans’ Resources: www.alz.org/ISTAARTclinicians
ALZ-NET: https://www.alz-net.org/
Podcast CMEs: www.alz.org/ISTAARTpodcastCME
Alzheimer's Association International Conference® 2025 (AAIC®): alz.org/AAIC
Alzheimer's Association Scientific Meetings: alz.org/scientificmeetings
Alzheimer's Association Journal Family: alz.org/journals
Social: #ISTAART @ISTAART

The views and opinions expressed in this podcast are solely those of the guests and do not necessarily reflect those of the Alzheimer's Association. The Alzheimer's Association does not endorse any external product or service. This podcast is for informational purposes and is not intended to provide medical advice, please consult your physician.
Hosted on Acast. See acast.com/privacy for more information.

Hearing loss increases the risk of developing dementia in later years. In this episode of ISTAART Voices, researchers Dr. Joshua Stevenson-Hoare and Dr. Kouki Tomida dissect the ways in which hearing loss may accelerate dementia progression. Through studies conducted in Germany and Japan, their works explore how early hearing difficulties and reduced conversation could signal future cognitive decline, offering compelling perspectives on early intervention and prevention strategies.

Special thanks to ISTAART Ambassador Michelle Chiu for her contributions to the production of this episode of ISTAART Voices.

Links
Show page: alz.org/ISTAARTpodcast
ISTAART: alz.org/ISTAART
Featured paper 1: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/dad2.12586/utm_source=podcast&utm_medium=newsletter&utm_campaign=IVS1_KT&utm_id=ISTAARTVoices
Featured paper 2: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/dad2.12624/utm_source=podcast&utm_medium=newsletter&utm_campaign=IVS1_JSH&utm_id=ISTAARTVoices
Dr. Kouki Tomida: https://orcid.org/0000-0002-7397-8224
Dr. Joshua Stevenson-Hoare: https://www.dkfz.de/en/clinical-epidemiology-and-aging-research/our-team
Podcast CMEs: www.alz.org/ISTAARTpodcastCME
Alzheimer's Association International Conference® 2025 (AAIC®): alz.org/AAIC
Alzheimer's Association Scientific Meetings: alz.org/scientificmeetings
Alzheimer's Association Journal Family: alz.org/journals
Social: #ISTAART @ISTAART

The views and opinions expressed in this podcast are solely those of the guests and do not necessarily reflect those of the Alzheimer's Association. The Alzheimer's Association does not endorse any external product or service. This podcast is for informational purposes and is not intended to provide medical advice, please consult your physician.
Hosted on Acast. See acast.com/privacy for more information.